Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CYP2A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OXCT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHLDB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NELL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPSECS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996902 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101928525 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTG1P4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSE1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFNG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC642852 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on